NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000002375

Registered date:01/09/2009

Usefulness of oral kanamycin for retrograde infection after biliary stent placement

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedObstructive jaundice
Date of first enrollment2009/09/01
Target sample size80
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)plastic stent - oral kanamycin in group plastic stent - group without oral kanamycin metal stent - oral kanamycin in group metal stent - group without oral kanamycin

Outcome(s)

Primary Outcomebiliary stent occlusion
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum100years-old
GenderMale and Female
Include criteria
Exclude criteria1.patients already have oral kanamycin prior to stenting 2.history of upper gastrointestinal 3.patients with hearing loss 4.severe renal dysfunction (serum creatinine> 2.0mg/dl) the merger of the patient 5.patients unable to take oral medication 6.pregnant women, nursing mothers, and pregnant women suspected 7.other patients deemed inappropriate for this exam by the doctor

Related Information

Contact

public contact
Name shingo kato
Address Japan
Telephone 045-787-2800
E-mail
Affiliation Yokohama City University Hospital Gastroenterology Division
scientific contact
Name shingo kato
Address 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa,236-0004, Japan Japan
Telephone 045-787-2800
E-mail
Affiliation Yokohama City University Hospital Gastroenterology Division